Campath Pivotal and Supportive Studies (30 mg 3x/week)

Supportive Studies

125-005 Relapsed / failed 32

prior therapy

125-009 Relapsed / failed 24

fludarabine

Pivotal Study

CAM211 Failed fludarabine 93

Total Patients 149

Study Number Previous Treatment No. of Patients

Efficacy Results

Previous slide

Next slide

Back to first slide

View graphic version